This morning, the Delaware House & Human Development Committee advanced House Bill 285, enabling physicians in the state to have increased discretion in recommending medical cannabis products to their patients. NORML’s Deputy Director, Paul Armentano, and Committee Vice-Chair, Rep. Eric Morrison, have expressed support for this measure, advocating for a patient-doctor decision-making process. Legislation legalizing adult-use marijuana possession and retail sales was approved last year, with the state’s medical access program already having approximately 15,000 enrolled patients. Full text of NORML’s testimony is accessible online, and an action alert in support of HB 285 is also available.